Last Posted: Mar 18, 2019
- A gene expression signature of Retinoblastoma loss-of-function predicts resistance to neoadjuvant chemotherapy in ER-positive/HER2-positive breast cancer patients.
Risi Emanuela et al. Breast cancer research and treatment 2018 Jul 170(2) 329-341 - A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer.
Rudolph M et al. Breast cancer research and treatment 2018 Jun 169(3) 457-467 - Adjuvant versus neoadjuvant chemotherapy in triple-negative breast cancer patients with BRCA mutations.
Clifton Katherine et al. Breast cancer research and treatment 2018 Jul 170(1) 101-109 - BRCA mutations and their influence on pathological complete response and prognosis in a clinical cohort of neoadjuvantly treated breast cancer patients.
Wunderle Marius et al. Breast cancer research and treatment 2018 Aug 171(1) 85-94 - Circulating microRNAs from the miR-106a-363 cluster on chromosome X as novel diagnostic biomarkers for breast cancer.
Li Minghui et al. Breast cancer research and treatment 2018 Jul 170(2) 257-270 - New emerging roles of microRNAs in breast cancer.
Mandujano-Tinoco Edna Ayerim et al. Breast cancer research and treatment 2018 Sep 171(2) 247-259 - Stand-Alone Artificial Intelligence for Breast Cancer Detection in Mammography: Comparison With 101 Radiologists.
Rodriguez-Ruiz Alejandro et al. Journal of the National Cancer Institute 2019 Mar - Six novel immunoglobulin genes as biomarkers for better prognosis in triple-negative breast cancer by gene co-expression network analysis
HM Hsu et al, Scientific Reports, March 14, 2019 - Concerns and Expectations of Risk-Reducing Surgery in Women with Hereditary Breast and Ovarian Cancer Syndrome.
Modaffari Paola et al. Journal of clinical medicine 2019 Mar 8(3) - Factors Determining Anthracycline Use in Hormone Receptor Positive, Early-Stage Breast Cancer.
Henderson Jordan et al. Clinical breast cancer 2019 Feb
.png)
No hay comentarios:
Publicar un comentario